Market Tracker

03/27 7:45pm ET

X T L Biopharmaceuticals Ltd (NASDAQ:XTLB)

2.55
Delayed Data
As of Mar 27
 +0.31 / +13.84%
Today’s Change
1.55
Today|||52-Week Range
5.04
+28.79%
Year-to-Date
No recent news for X T L Biopharmaceuticals Ltd.

Today’s Trading

Previous close2.24
Today’s open2.28
Day’s range2.28 - 2.55
Volume3,631
Average volume (3 months)13,815
Market cap$30.3M
Dividend yield--
Data as of 3:41pm ET, 03/27/2015

Growth & Valuation

Earnings growth (last year)-83.83%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+153.36%
P/E ratio--
Price/Sales13.65
Price/Book4.62

Competitors

 Today’s
change
Today’s
% change
--Axim Biotechnologies...+0.20+19.05%
EVOKEvoke Pharma Inc-0.01-0.14%
ATOSAtossa Genetics Inc+0.04+2.30%
NUINNutrastar Internatio...0.000.00%
Data as of 4:00pm ET, 03/27/2015

Financials

Last reporting dateSeptember 8, 2008
EPS forecast (this quarter)-$0.04
Annual revenue (last year)$2.4M
Annual profit (last year)-$2.5M
Net profit margin-104.52%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer
Joshua Levine
Chief Financial Officer
David Kestenbaum
Corporate headquarters
Herzliya, --

Forecasts